Diabetying & lifestyle as medicine programme for people with diabetes type II in primary care * an implementation pilot - Diabetyping & lifestyle as a medicine

TNO0 sites16 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sponsor

TNO

•The participants will be recruited from the T2D patient population of healthcare partnership Stevenshof. Four GPA\*s work for healthcare partnership Stevenshof. Each GPA will select two T2D patients in each of the two study phases. These patients should meet one of the following requirements:
•\- Patient is newly diagnosed with T2D
•\- Patient is about to start Metformin
•\- Patient is about to start with a second oral drug (like SU\-derivates)
•\- Patient is about to start with an injectable drug (Insulin or GLP\-1\);Besides that, the patients should meet the following inclusion criteria:
•\- Aged between 30\-80
•\- Have a BMI between 25\-35
•\- Willing and able to sign the informed consent form
•\- Able to fill in the 360\-degree questionnaire which is in Dutch
•\- Able to work with computers (e.g. for filling in digital questionnaires)

•A candidate who meets any of the following criteria will be excluded from participation in this study:
•\- Dialysis patients
•\- Possible limiting personal circumstances (e.g. unemployed, illness in the family, dept restructuring)
•\- Patients under treatment of a psychiatrist
•\- Incapacitated patients
•\- Patients in a palliative phase